BME Group announces that it has divested twelve excess real estate assets of its Swiss Operating Company ‘BMS’ (Building Materials Suisse) to five buyers, consisting of HIAG, Swissroc Industrial Opportunities, Orllati Real Estate, IBOR and Weibel. The divestment will further enable BMS to deliver on its strategic roadmap while maximizing efficiency throughout its organization.
As part of the ongoing review of its footprint and real estate portfolio, BMS identified 12 properties with redevelopment potential, which are no longer required for its operation or required in a different configuration. Of the twelve divested assets, BMS has entered into long term lease agreements for five of the assets with two of the buyers (HIAG and Swissroc). Both buyers will invest significantly in selected sites, allowing BMS to optimize its footprint and further improve its service offering to customers.
Total gross proceeds of the divestments are CHF 94.5 million and the agreements were signed before end of March 2021. Advisors to BMS are CBRE (Real Estate), Lenz & Staehelin (Legal) and Ernst & Young (Tax).
BME Group announces it has reached an agreement, subject to customary competition and foreign investment clearances, to acquire Grupo BMV, a market leading supplier of interior finishing building materials with […]
In a year which was marked by a global pandemic, our highest priority was to protect our employees and customers whilst ensuring that we keep on servicing our customers successfully. […]
BME Group (BME) and the shareholders of the Mahler Group have reached an agreement on the sale of its shares to BME. The Mahler Group, a leading general building materials […]
BME Group enters into exclusive negotiations to acquire Saint Gobain’s building distribution activities in the Netherlands
BME Group announces that it has entered into exclusive negotiations with Saint Gobain in preparation for the acquisition of Saint-Gobain Building Distribution the Netherlands (SGBD NL). SGBD NL is active […]
Strategic initiatives on track Financial results H1 2020 versus H1 2019• Revenue slightly up (+0.4%) to €1,853 million• Normalized EBITDA increased by 3.1% to €124 million• Normalized EBITDA margin increased […]